SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 63.80 |
| Enterprise Value ($M) | 76.03 |
| Book Value ($M) | 44.93 |
| Book Value / Share | 1.02 |
| Price / Book | 1.42 |
| NCAV ($M) | -29.87 |
| NCAV / Share | -0.68 |
| Price / NCAV | -2.14 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.88 |
| Return on Assets (ROA) | -0.32 |
| Return on Equity (ROE) | -0.63 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 9.53 |
| Current Ratio | 9.53 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 51.72 |
| Assets | 126.52 |
| Liabilities | 81.59 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Genextra S.p.A. | |||
| 13G | Sofinnova Partners SAS | |||
| 13G/A | Tang Capital Management Llc | 0.00 | ||
| 13D | Lamond David | 10.10 | ||
| 13G/A | Tang Capital Partners Lp | 7.50 | -11.05 | |
| 13G/A | BML Investment Partners, L.P. | 0.00 | -100.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 14,335 | 43,477 | 32.97 | |
| 31,461 | 75,892 | 41.45 | |
| 61,330 | 186,343 | 32.91 | |
| 29,871 | 83,423 | 35.81 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| PTCT – PTC Therapeutics, Inc. | PYXS – Pyxis Oncology, Inc. |
| QDEL – QuidelOrtho Corporation | QURE – uniQure N.V. |
| RARE – Ultragenyx Pharmaceutical Inc. |
Financial data and stock pages provided by
Fintel.io